Ruxolitinib partially reverses functional NK cell deficiency in patients with STAT1 gain-of-function mutations
The Journal of Allergy and Clinical Immunology | Nov 04, 2017
Efficacy and safety of AR101 in oral immunotherapy for peanut allergy: Results of ARC001, a randomized, double-blind, placebo-controlled phase 2 clinical trial
The Journal of Allergy and Clinical Immunology: In Practice | Nov 03, 2017
Step-up empiric elimination diet for pediatric and adult eosinophilic esophagitis: The 2-4-6 Study
The Journal of Allergy and Clinical Immunology | Nov 01, 2017
Most read this week